跳至主要内容
临床试验/CTRI/2020/11/028803
CTRI/2020/11/028803尚未招募未知

A prospective study to evaluate the bacteriological and antigen-specific immunological responses induced by MIP and/ BCG vaccines as adjunctive treatment (immunotherapy) in multibacillary leprosy patients treated with multidrug therapy

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Treatment naïve cases of MB leprosy classified according to WHO classification.
  • 2. Age group: 12- 60 years
  • 3. Patients willing to give consent (for patients aged 12-18years willing to give assent and consent from the legally acceptable representative)

排除标准

  • Paucibacillary (PB) cases of leprosy
  • 2. Defaulter cases
  • 3. Relapse cases
  • 4. Patients on steroids- prednisolone dose >20mg/day for more than 2 weeks
  • 5. Pregnancy or breast feeding
  • 6. With medical co-morbidities like diabetes, cancer, history of or active pulmonary tuberculosis
  • 7. People living with HIV/AIDS

研究者

发起方
ICMR

相似试验

Evaluation of bacteriological and immunological... | 临床试验